Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Farmers Insurance
Cantor Fitzgerald
US Department of Justice
Express Scripts
Harvard Business School
Argus Health

Generated: March 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 089887

« Back to Dashboard

NDA 089887 describes MEXATE-AQ PRESERVED, which is a drug marketed by Bristol Myers Squibb and is included in one NDA. Additional details are available on the MEXATE-AQ PRESERVED profile page.

The generic ingredient in MEXATE-AQ PRESERVED is methotrexate sodium. There are twenty drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the methotrexate sodium profile page.
Summary for 089887
Applicant:Bristol Myers Squibb
Ingredient:methotrexate sodium
Therapeutic Class:Immunological Agents
Formulation / Manufacturing:see details

Profile for product number 001

Approval Date:Apr 14, 1989TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.